查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1830959

无针给药设备市场

Needle-Free Drug Delivery Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

无针给药装置市场预计将从 2024 年的 160.1 亿美元成长到 2031 年的 284.2 亿美元，2025 年至 2031 年期间的年复合成长率(CAGR) 为 8.5%。推动无针给药装置市场发展的关键趋势包括策略性倡议的增加和医疗保健整合软体的采用。

无针给药设备市场分析：针头有感染多种疾病的风险，包括爱滋病毒 (HIV)，如果操作不当，还可能造成伤害。根据《MEDICSEN：用于无痛给药的无针智慧贴片》一文，美国每天有超过 2,000 人遭受针刺伤，每年造成超过 30 亿美元的相关费用。无针给药设备的采用可显着降低此类伤害和疾病的风险。因此，针刺伤发生率的上升和治疗费用的增加正在推动无针给药设备市场的成长。

无针给药装置市场概况

无针给药方法包括动力喷雾器、喷射注射器、吸入器和皮肤贴片。这项技术可以缓解患者因针头引起的焦虑。无针装置可有效注射多种药物，并且与传统针头生物等效。无针给药系统的优点在于减轻疼痛、快速给药、无需针头处置以及可自行给药等，这些都是推动此类装置需求成长的主要动力。

战略洞察

无针给药设备市场的驱动因素与机会

慢性病和生活方式紊乱发病率上升将使市场受益

心臟病、糖尿病和癌症等慢性疾病是全球死亡和残疾的主要原因之一。根据美国疾病管制与预防中心 (CDC) 的数据，2021 年约有 3,840 万美国人被诊断出患有糖尿病。为了控製糖尿病，需要定期将胰岛素注射到皮下层。糖尿病的日益普及推动了胰岛素注射的需求。各公司越来越重视开发无针胰岛素输送系统，以防止针刺伤。例如，Medicsen 正在研发 SmartPatch，以提高胰岛素输送效率。

家庭医疗保健日益受到青睐—无针给药市场的机会

从医院和长期护理机构向家庭护理环境的转变，增强了患者与医疗服务提供者之间更佳、更一致、更及时的互动，而云端和行动医疗设备的日益普及，则促进了这一转变。在发展中国家，接受家庭治疗的患者数量历来有限。与电子健康记录 (EHR) 整合的智慧贴片和喷射注射器使医生能够远端监控药物剂量。借助无针给药设备，患者可以按照医疗服务提供者的处方，方便地自行用药。因此，对家庭医疗保健的日益重视以及对技术先进产品的采用预计将在预测期内为市场创造成长机会。

无针给药装置市场細項分析报告

对无针药物输送装置市场进行分析的关键部分包括类型和应用。

依类型划分，无针给药装置市场分为吸入器、喷射注射器、新型针头、透皮贴片等。喷射注射器在2023年占据了最大的市场。依应用划分，市场分为胰岛素输送、疫苗接种、疼痛管理等。胰岛素输送领域在2023年占据了市场主导地位。无针给药装置市场份额的地理分析：无针给药装置市场报告的地理范围分为五个区域：北美、亚太地区、欧洲、中东和非洲以及南美。

2023年，北美是无针给药设备市场的领先地区。该地区的成长动力源于生物製药和生物技术公司对罕见疾病药物的需求不断增长、主要市场参与者的加入、新产品的推出、针刺伤发生率的上升，以及学术机构和製药公司大力投入的研发。此外，预计未来几年亚太地区将呈现最高的复合年增长率。

无针给药装置市场的最新发展与新闻

无针给药设备市场的评估是基于从一手资料和二手资料中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。以下是无针给药设备市场的一些最新发展和策略：

NovaXS 成立于加州大学柏克莱分校，已开发出正在申请专利的 Telosis 技术，可在短短 0.3 秒内无需针头即可注射细流药物，并分析注射资料以促进更明智的健康决策。 （资料来源：NovaXS Biotech，新闻稿，2022 年）NuGen Medical Devices Inc. 在加拿大推出了 InsuJet 设备。 SOL-MILLENNIUM 医疗集团作为参展商参加了 2022 年加拿大糖尿病协会/加拿大内分泌与代谢学会 (CSEM) 专业会议，并在会上向加拿大市场推出了 InsuJet 产品。 （资料来源：NuGen Medical Devices Inc，公司网站，2022 年）无针给药装置市场报告的范围无针给药装置市场报告的覆盖范围和可交付成果题为“无针给药装置市场规模和预测（2023-2031 年）”的报告对市场进行了全面的分析，涵盖以下领域：

范围内所有关键市场领域的全球、区域和国家层面的市场规模和预测市场动态，例如驱动因素、限制因素和重大机会关键的未来趋势深入的 PEST 和 SWOT 分析全球和区域市场分析，重点介绍关键趋势、主要参与者、法规和最新发展行业格局和竞争分析，包括市场集中度、热图分析、知名参与者和最新进展详细的公司简介

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：无针给药设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：无针给药装置市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：无针给药装置市场－全球市场分析

  • 无针给药装置 - 全球市场概览
  • 无针给药装置－全球市场及2031年预测

第七章：无针给药装置市场-收入分析-按类型，2021-2031

  • 概述
  • 喷射器
  • 透皮贴剂
  • 吸入器
  • 新型无针
  • 其他的

第 8 章：无针给药设备市场 - 收入分析 - 按应用，2021-2031 年

  • 概述
  • 疫苗接种
  • 疼痛管理
  • 胰岛素输送
  • 其他的

第九章：无针给药装置市场-收入分析，2021-2031-地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 11 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 12 章：无针给药装置市场 - 主要公司简介

  • NuGen Medical Devices
  • NovaXS Biotech
  • GlaxoSmithKline
  • AstraZeneca
  • Roche
  • Boehringer Ingelheim
  • Merck
  • Cipla
  • Novartis
  • Teva Pharmaceuticals
  • Omron Healthcare
  • Sumitomo Pharma Co. Ltd

第 13 章：附录

简介目录
Product Code: TIPHE100001168

The market for needle-free drug delivery devices is anticipated to grow from US$ 16.01 billion in 2024 to US$ 28.42 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.5% during the period from 2025 to 2031. Key trends driving the needle-free drug delivery devices market include an increase in strategic initiatives and the adoption of healthcare integration software.

Analysis of the Needle-Free Drug Delivery Devices Market

Needles pose risks of various diseases, including HIV, and can cause injuries if not handled with care. According to the article "MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY", more than 2,000 individuals in the US experience needlestick injuries daily, resulting in over US$ 3 billion in related costs each year. The adoption of needle-free drug delivery devices significantly reduces the risk of such injuries and diseases. Consequently, the rising incidence of needlestick injuries and increased spending on treatment are propelling the growth of the needle-free drug delivery devices market.

Overview of the Needle-Free Drug Delivery Devices Market

Needle-free drug delivery methods include power sprays, jet injectors, inhalers, and skin patches. This technology alleviates patient anxiety associated with needles. Needle-free devices provide effective injections for a variety of medications and are bioequivalent to traditional needles. The benefits of needle-free delivery systems, such as reduced pain, rapid administration, elimination of needle disposal issues, and the ability for self-administration, are primarily driving the rising demand for these devices.

Strategic Insights

Drivers and Opportunities in the Needle-Free Drug Delivery Devices Market

Increasing Incidence of Chronic Diseases and Lifestyle Disorders to Benefit the Market

Chronic conditions like heart disease, diabetes, and cancer are among the leading causes of mortality and disability globally. According to the Centers for Disease Control and Prevention (CDC), approximately 38.4 million Americans were diagnosed with diabetes in 2021. To manage diabetes, insulin is regularly injected into the subcutaneous layer. The growing prevalence of diabetes is driving the demand for insulin injections. Companies are increasingly focusing on developing needle-free insulin delivery systems to prevent needlestick injuries. For example, Medicsen is working on the SmartPatch to enhance insulin delivery efficiency.

Growing Preference for Home Healthcare - A Chance for the Needle-Free Drug Delivery Market

The transition from hospitals and long-term care facilities to home care settings enhances the potential for improved, consistent, and timely interactions between patients and healthcare providers, facilitated by the increasing use of cloud-based and mobile medical devices. In developing nations, the number of patients receiving home therapy has historically been limited. Smart patches and jet injectors that integrate with electronic health records (EHR) enable doctors to monitor dosages remotely. With needle-free drug delivery devices, patients can conveniently self-administer their medications as prescribed by their healthcare providers. Therefore, the rising emphasis on home healthcare and the adoption of technologically advanced products are expected to create growth opportunities for the market during the forecast period.

Segmentation Analysis of the Needle-Free Drug Delivery Devices Market Report

Key segments contributing to the analysis of the needle-free drug delivery devices market include type and application.

By type, the needle-free drug delivery devices market is categorized into inhalers, jet injectors, novel needles, transdermal patches, and others. The jet injectors segment accounted for the largest market share in 2023.By application, the market is divided into insulin delivery, vaccination, pain management, and others. The insulin delivery segment led the market in 2023.

Geographical Analysis of the Needle-Free Drug Delivery Devices Market Share

The geographical scope of the needle-free drug delivery devices market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America.

North America was the leading region in the needle-free drug delivery devices market in 2023. The growth in this region is driven by the rising demand for medications for rare diseases from biopharmaceutical and biotechnology firms, the presence of major market players, an increase in product launches, a growing incidence of needlestick injuries, and extensive research and development efforts by academic institutions and pharmaceutical companies. Additionally, the Asia Pacific region is expected to exhibit the highest CAGR in the coming years.

Recent Developments and News in the Needle-Free Drug Delivery Devices Market

The evaluation of the needle-free drug delivery devices market is based on qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Below are some recent developments and strategies in the needle-free drug delivery devices market:

NovaXS, established at the University of California, Berkeley, has developed its patent-pending Telosis technology, which administers a narrow stream of medication without a needle in just 0.3 seconds and analyzes injection data to facilitate smarter health decisions. (Source: NovaXS BIotech, Press Release, 2022)NuGen Medical Devices Inc. introduced InsuJet devices in Canada. SOL-MILLENNIUM Medical Group participated as an exhibitor at the 2022 Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, where it launched the InsuJet product for the Canadian market. (Source: NuGen Medical Devices Inc, Company Website, 2022

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Needle-Free Drug Delivery Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Needle-Free Drug Delivery Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Needle-Free Drug Delivery Devices Market - Global Market Analysis

  • 6.1 Needle-Free Drug Delivery Devices - Global Market Overview
  • 6.2 Needle-Free Drug Delivery Devices - Global Market and Forecast to 2031

7. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 7.1 Overview
  • 7.2 Jet Injectors
  • 7.3 Transdermal Patch
  • 7.4 Inhaler
  • 7.5 Novel Needle-free
  • 7.6 Others

8. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Vaccination
  • 8.3 Pain Management
  • 8.4 Insulin Delivery
  • 8.5 Others

9. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Needle-Free Drug Delivery Devices Market Overview
    • 9.1.2 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts to 2031
    • 9.1.3 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Type
    • 9.1.4 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Application
    • 9.1.5 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Countries
      • 9.1.5.1 United States Needle-Free Drug Delivery Devices Market
        • 9.1.5.1.1 United States Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.1.2 United States Needle-Free Drug Delivery Devices Market, by Application
      • 9.1.5.2 Canada Needle-Free Drug Delivery Devices Market
        • 9.1.5.2.1 Canada Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.2.2 Canada Needle-Free Drug Delivery Devices Market, by Application
      • 9.1.5.3 Mexico Needle-Free Drug Delivery Devices Market
        • 9.1.5.3.1 Mexico Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.3.2 Mexico Needle-Free Drug Delivery Devices Market, by Application
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. Industry Landscape

  • 10.1 Mergers and Acquisitions
  • 10.2 Agreements, Collaborations, Joint Ventures
  • 10.3 New Product Launches
  • 10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Needle-Free Drug Delivery Devices Market - Key Company Profiles

  • 12.1 NuGen Medical Devices
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 NovaXS Biotech
  • 12.3 GlaxoSmithKline
  • 12.4 AstraZeneca
  • 12.5 Roche
  • 12.6 Boehringer Ingelheim
  • 12.7 Merck
  • 12.8 Cipla
  • 12.9 Novartis
  • 12.10 Teva Pharmaceuticals
  • 12.11 Omron Healthcare
  • 12.12 Sumitomo Pharma Co. Ltd

13. Appendix

  • 13.1 Glossary
  • 13.2 About The Insight Partners
  • 13.3 Market Intelligence Cloud